A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Multicenter, Double-blind, Randomized, Placebo-controlled Study on Mometasone Furoate Nasal Spray in Japanese Pediatric Subjects with Perennial Allergic Rhinitis
2014
Practica oto-rhino-laryngologica Suppl
Intranasal glucocorticoids effectively and safely alleviate the symptoms of allergic rhinitis, but treatment options from this drug class are still limited for the Japanese pediatric population. Objective: To evaluate the efficacy and tolerability of mometasone furoate nasal spray (MFNS) at a oncedaily dosage compared with a placebo spray (placebo) in Japanese children with perennial allergic rhinitis (PAR). Methods: In this randomized, double-blind, multicenter study, subjects aged 5~15 years
doi:10.5631/jibirinsuppl.138.34
fatcat:i2cc7qpwzjf7jiogqemnratskm